(Press-News.org) Among patients with chronic kidney disease, those with very low kidney function had a higher risk of having a heart attack than those with higher kidney function over a four-year period.
The link between higher LDL cholesterol and heart attack risk was weaker for patients with very low kidney function than for patients with higher kidney function.
60 million people globally have chronic kidney disease.
Washington, DC (May 16, 2013) — LDL cholesterol is not a useful marker of heart disease risk in patients with kidney disease, according to a study appearing in an upcoming issue of the Journal of the American Society of Nephrology (JASN). The finding suggests that other measurements should be used to assess kidney disease patients' cardiovascular health.
High LDL cholesterol is a strong marker of heart disease risk in the general population, but its use in people with chronic kidney disease (CKD) is unclear. To investigate, Marcello Tonelli, MD, FRCPC (University of Alberta, in Edmonton, Canada) and his colleagues studied 836,060 adults with CKD from the Alberta Kidney Disease Network between 2002 and 2009.
During an average follow-up of four years, 7762 patients were hospitalized for heart attacks, most of whom had the lowest levels of kidney function at the start of the study. Despite their higher overall risk of having a heart attack, the link between higher LDL cholesterol and heart attack risk was weaker for these patients than for patients with higher kidney function.
"This indicates that, although people with impaired kidney function are at high risk of cardiovascular events, LDL cholesterol is less useful as a marker of risk in this population," said Dr. Tonelli. "This in turn suggests that, unlike in the general population, criteria for cardioprotective treatments such as statins should not be based on LDL cholesterol levels in people with chronic kidney disease, and it argues instead for an approach that is based on absolute cardiovascular risk."
In an accompanying editorial, Julie Lin, MD (Genzyme Corporation and Brigham and Women's Hospital) noted that further study of kidney dysfunction and cardiovascular
risk represents an important area of healthcare research. "The very large total at-risk population of CKD and end stage renal disease patients who will experience morbidity and mortality from cardiovascular disease is calling out for more research to lead directly to improved management and outcomes as soon as possible."
###
Study co-authors include Paul Muntner, PhD, Anita Lloyd, Braden Manns, MD, Scott Klarenbach, MD, Neesh Pannu, MD, Matthew James, MD, PhD, and Brenda Hemmelgarn MD, PhD.
Disclosures: This work was supported by an interdisciplinary team grant from the Alberta Heritage Foundation for Medical Research (AHFMR). Drs. Hemmelgarn, Tonelli, Klarenbach and Manns were supported by career salary awards from AHFMR. Dr. Tonelli was also supported by a Government of Canada Research Chair in the optimal care of people with chronic kidney disease, and Dr. Hemmelgarn by the Roy and Vi Baay Chair in Kidney Research. Drs. Hemmelgarn, Klarenbach, Manns, and Tonelli were all supported by a joint initiative between Alberta Health and Wellness and the Universities of Alberta and Calgary. Dr. Muntner receives research funding from Amgen Inc. Dr. Tonelli has served on advisory boards for Merck; honoraria were donated to charity.
The article, entitled "Association between LDL-C and Risk of Myocardial Infarction in CKD," will appear online at http://jasn.asnjournals.org/ on May 16, 2013, doi: 10.1681/ASN.2012080870.
The editorial, entitled "A Piece of the Puzzle in the Cardiorenal Conundrum," will appear online at http://jasn.asnjournals.org/ on May 16, 2013, doi: 10.1681/ASN.2013040420.
The content of this article does not reflect the views or opinions of The American Society of Nephrology (ASN). Responsibility for the information and views expressed therein lies entirely with the author(s). ASN does not offer medical advice. All content in ASN publications is for informational purposes only, and is not intended to cover all possible uses, directions, precautions, drug interactions, or adverse effects. This content should not be used during a medical emergency or for the diagnosis or treatment of any medical condition. Please consult your doctor or other qualified health care provider if you have any questions about a medical condition, or before taking any drug, changing your diet or commencing or discontinuing any course of treatment. Do not ignore or delay obtaining professional medical advice because of information accessed through ASN. Call 911 or your doctor for all medical emergencies.
Founded in 1966, and with more than 13,500 members, the American Society of Nephrology (ASN) leads the fight against kidney disease by educating health professionals, sharing new knowledge, advancing research, and advocating the highest quality care for patients.
END
Massachusetts' healthcare reform didn't result in substantially more hospital use or higher costs, according to data presented at the American Heart Association's Quality of Care and Outcomes Research Scientific Sessions 2013.
The findings were true even among safety-net hospitals, which often have an open-door policy to accept patients regardless of the ability to pay. These hospitals are most likely to care for people who need free services, use Medicaid or must pay their own hospital bills.
"In light of the Affordable Healthcare Act, we wanted to validate concerns ...
MAY 16, 2013—An ad hoc coalition of unlikely insurgents—scientists, journal editors and publishers, scholarly societies, and research funders across many scientific disciplines—today posted an international declaration calling on the world scientific community to eliminate the role of the journal impact factor (JIF) in evaluating research for funding, hiring, promotion, or institutional effectiveness.
The San Francisco Declaration on Research Assessment, or DORA, was framed by a group of journal editors, publishers, and others convened by the American Society for Cell ...
HOUSTON – (May 16, 2013) – In a paper published in Science Express, a group of experts led by bioethicists in the Center for Medical Ethics and Health Policy at Baylor College of Medicine provide a framework for the new American College of Medical Genetics and Genomics (ACMG) recommendations on reporting incidental findings in clinical exome and genome sequencing.
In March 2013, the ACMG recommended that all laboratories conducting clinical sequencing seek and report pathogenic and expected pathogenic mutations for a short list of carefully chosen genes and conditions. ...
This news release is available in German. Once introduced for biological pest control, Asian lady beetle Harmonia axyridis populations have been increasing uncontrollably in the US and Europe since the turn of the millennium. The species has been proliferating rapidly in Germany; conservationists fear that the Asian lady beetle will out-compete native beetle species. Scientists from the University of Giessen and the Max Planck Institute for Chemical Ecology in Jena, Germany, have now found the reason why this animal is so successful. Apart from a strongly antibiotic ...
Depressed middle-aged women have almost double the risk of having a stroke, according to research published in Stroke: Journal of the American Heart Association.
In a 12-year Australian study of 10,547 women 47-52 years old, researchers found that depressed women had a 2.4 times increased risk of stroke compared to those who weren't depressed. Even after researchers eliminated several factors that increase stroke risks, depressed women were still 1.9 times more likely to have a stroke.
"When treating women, doctors need to recognize the serious nature of poor mental health ...
Science publishes the article in Science Express, which facilitates rapid publication of select studies.
"This study is a breakthrough for our research group after years of work. When we reduce the production of the enzyme in mice, the development of all the clinical symptoms of progeria is reduced or blocked. We have also studied cultured cells from children with progeria, and can see that when the enzyme is inhibited, the growth of the cells increases by the same mechanism as in mouse cells," says Martin Bergö, Professor at the Sahlgrenska Academy, University of Gothenburg ...
DETROIT – If you're a left-brain thinker, chances are you use your right hand to hold your cell phone up to your right ear, according to a newly published study from Henry Ford Hospital in Detroit.
The study – to appear online in JAMA Otolaryngology-Head & Neck Surgery – shows a strong correlation between brain dominance and the ear used to listen to a cell phone. More than 70% of participants held their cell phone up to the ear on the same side as their dominant hand, the study finds.
Left-brain dominant people – who account for about 95% of the population and have ...
Promotion of influenza vaccines is one of the most visible and aggressive public health policies today, writes Doshi. Today around 135 million doses of influenza vaccine annually enter the US market, with vaccinations administered in drug stores, supermarkets - even some drive-throughs.
This enormous growth has not been fuelled by popular demand but instead by a public health campaign that delivers a straightforward message: influenza is a serious disease, we are all at risk of complications from influenza, the flu shot is virtually risk free, and vaccination saves lives.
Yet, ...
MINNEAPOLIS/ST. PAUL (05/15/2012)—Informed consent is the backbone of patient care. Genetic testing has long required patient consent and patients have had a "right not to know" the results. However, as 21st century medicine now begins to use the tools of genome sequencing, an enormous debate has erupted over whether patients' rights will continue in an era of medical genomics.
Recent recommendations from the American College of Medical Genetics and Genomics (ACMG) suggest no. On March 22, the ACMG released recommendations stating that when clinical sequencing is undertaken ...
Boston, MA – Bicycle engineering guidelines often used by state regulators to design bicycle facilities need to be overhauled to reflect current cyclists' preferences and safety data, according to a new study from Harvard School of Public Health (HSPH) researchers. They say that U.S. guidelines should be expanded to offer cyclists more riding options and call for endorsing cycle tracks – physically separated, bicycle-exclusive paths adjacent to sidewalks – to encourage more people of all ages to ride bicycles.
The study appears online May 16, 2013 and will appear in ...
